Jianmin Pharmaceutical Group ,Ltd. Receivables

As of the most recent data (June 2026), 600976.SS shows a receivables of $1.2B. That compares with $1.2B in the prior-year period — down 0.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600976.SS's receivables is now $1.2B (was $1.2B) — a 0.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jianmin Pharmaceutical Group ,Ltd. is outperforming or lagging.

Tracking 600976.SS's receivables over time shows whether Jianmin Pharmaceutical Group ,Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2B That compares with $1.2B in the prior-year period — down 0.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Jianmin Pharmaceutical Group ,Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.2B) with ownership activity and broader fundamentals.